Evidence map›Paper›PMID 34631669›Full record

ReviewFrontiers in chemistry2021

Progress in the Application of Carbon Dots-Based Nanozymes.

Jun Jin, Linlin Li, Lihui Zhang, Zhihui Luan, Shuquan Xin, Kai Song

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Preparation and Application of Carbon Dots Nanozymes.Antioxidants (Basel, Switzerland) · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jun JinSchool of Life Sciences, Changchun Normal University, Changchun, China.
Linlin LiSchool of Life Sciences, Changchun Normal University, Changchun, China.
Lihui ZhangSchool of Life Sciences, Changchun Normal University, Changchun, China.
Zhihui LuanSchool of Life Sciences, Changchun Normal University, Changchun, China.
Shuquan XinSchool of Life Sciences, Changchun Normal University, Changchun, China.
Kai SongSchool of Life Sciences, Changchun Normal University, Changchun, China.
Changchun Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As functional nanomaterials with simulating enzyme-like properties, nanozymes can not only overcome the inherent limitations of natural enzymes in terms of stability and preparation cost but also possess design, versatility, maneuverability, and applicability of nanomaterials. Therefore, they can be combined with other materials to form composite nanomaterials with superior performance, which has garnered considerable attention. Carbon dots (CDs) are an ideal choice for these composite materials due to their unique physical and chemical properties, such as excellent water dispersion, stable chemical inertness, high photobleaching resistance, and superior surface engineering. With the continuous emergence of various CDs-based nanozymes, it is vital to thoroughly understand their working principle, performance evaluation, and application scope. This review comprehensively discusses the recent advantages and disadvantages of CDs-based nanozymes in biomedicine, catalysis, sensing, detection aspects. It is expected to provide valuable insights into developing novel CDs-based nanozymes.

Indexed as

biomedicinecarbon dotscatalysisdetectionnanozymessensing

Identifiers

PMID34631669
PMCPMC8497709
OpenAlexW3202727025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.